These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33973356)

  • 1. Astragaloside alleviates alcoholic fatty liver disease by suppressing oxidative stress.
    Jiang ZB; Gao J; Chai YH; Li W; Luo YF; Chen YZ
    Kaohsiung J Med Sci; 2021 Aug; 37(8):718-729. PubMed ID: 33973356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of E Se tea extracts against alcoholic fatty liver disease induced by high fat/alcohol diet: In vivo biological evaluation and molecular docking study.
    Wang Y; Fan Z; Yang M; Wang Y; Cao J; Khan A; Liu Y; Cheng G
    Phytomedicine; 2022 Jul; 101():154113. PubMed ID: 35490493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease.
    Liang XY; Hong FF; Yang SL
    Diabetes Metab Syndr Obes; 2021; 14():1871-1883. PubMed ID: 33953586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous Extract of Pepino (
    Hsu JY; Lin HH; Hsu CC; Chen BC; Chen JH
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Oxidative Stress in Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Preclinical Studies.
    Rabelo ACS; Andrade AKL; Costa DC
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of hedgehog pathway is required for the protective effects of magnesium isoglycyrrhizinate against ethanol-induced hepatocyte steatosis and apoptosis.
    Lu C; Xu W; Shao J; Zhang F; Chen A; Zheng S
    IUBMB Life; 2017 Jul; 69(7):540-552. PubMed ID: 28500689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of astragaloside IV on oxidative damages of chang liver cell induced by ethanol and H2O2].
    Han L; Li J; Lin X; Ma YF; Huang YF
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4430-5. PubMed ID: 25850280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance.
    Kong L; Chen J; Ji X; Qin Q; Yang H; Liu D; Li D; Sun M
    J Exp Clin Cancer Res; 2021 Jan; 40(1):18. PubMed ID: 33413501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways.
    Wei Z; Xue Y; Xue Y; Cheng J; Lv G; Chu L; Ma Z; Guan S
    J Pharmacol Sci; 2021 Sep; 147(1):72-80. PubMed ID: 34294375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function.
    Luo Y; Wan Q; Xu M; Zhou Q; Chen X; Yin D; He H; He M
    Chem Biol Interact; 2019 Aug; 309():108723. PubMed ID: 31228469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe
    Hua YQ; Zeng Y; Xu J; Xu XL
    Phytomedicine; 2021 Jan; 81():153412. PubMed ID: 33234364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zeaxanthin dipalmitate therapeutically improves hepatic functions in an alcoholic fatty liver disease model through modulating MAPK pathway.
    Xiao J; Wang J; Xing F; Han T; Jiao R; Liong EC; Fung ML; So KF; Tipoe GL
    PLoS One; 2014; 9(4):e95214. PubMed ID: 24740309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV inhibits palmitate-mediated oxidative stress and fibrosis in human glomerular mesangial cells via downregulation of CD36 expression.
    Su Y; Chen Q; Ma K; Ju Y; Ji T; Wang Z; Li W; Li W
    Pharmacol Rep; 2019 Apr; 71(2):319-329. PubMed ID: 30826573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production.
    Ma Z; Zhang Y; Li Q; Xu M; Bai J; Wu S
    PLoS One; 2017; 12(8):e0183426. PubMed ID: 28817659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of Taraxasterol against Ethanol-Induced Liver Injury by Regulating CYP2E1/Nrf2/HO-1 and NF-
    Xu L; Yu Y; Sang R; Li J; Ge B; Zhang X
    Oxid Med Cell Longev; 2018; 2018():8284107. PubMed ID: 30344887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
    Guan FY; Yang SJ; Liu J; Yang SR
    Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV Alleviates Ammonia-Induced Apoptosis and Oxidative Stress in Bovine Mammary Epithelial Cells.
    Wang F; Zhao Y; Chen S; Chen L; Sun L; Cao M; Li C; Zhou X
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the Janus Kinase 2 and Signal Transducer and Activator of Transcription 3 Signaling Pathway.
    Xu Z; Liu W; Huang H
    Pharmacology; 2020; 105(3-4):181-189. PubMed ID: 31825924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.